Innovation
7 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 41 times.
| Year | Filings |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 1 |
Social engagement
Social engagement: 1.1K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
11 investors on record; lead investors include Morningside.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 73% |
| Accelerator & incubator | 2 | 18% |
| Other / undisclosed | 1 | 9% |
Recent activity
24 Jun 2026
Event
Ophthalmology Tech Forum panel discussion
22 Jun 2026
Event
Evercore Private Company Conference
1 May 2026
Event
Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting